Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Before-and-after trial of Neurotec in fibromyalgia
IRCT138708061411N1Phase 2Completed
- Sponsor
- Pars Roos
- Start
- Apr 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Neurotec in fibromyalgia (FM), sponsored by Pars Roos. Started Apr 2008; status: completed.
02
Drugs
Neurotec
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on IRCT138708061411N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138708061411N1.